Predictors of disease severity in children with asthma in Hartford, Connecticut

Clare D Ramsey1, Juan C Celedón, Diane L Sredl

  • 1Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. recdr@channing.harvard.edu

Pediatric Pulmonology
|January 26, 2005
PubMed

Insights

Asthma severity in children is linked to ethnicity and allergen exposure. African-American and Puerto Rican children, along with cockroach allergen sensitization, predict more severe childhood asthma.

Area of Science:

  • Pediatrics
  • Allergy and Immunology
  • Public Health

Background:

  • Childhood asthma is a significant public health concern in the U.S., disproportionately affecting minority populations.
  • Understanding risk factors for asthma severity is crucial for effective management and intervention.

Purpose of the Study:

  • To investigate the relationship between ethnicity, allergen sensitization, spirometry, and asthma severity in children.
  • To identify predictors of severe asthma in a pediatric population in Hartford, Connecticut.

Main Methods:

  • A cross-sectional study involving 438 children (aged 4-18) in an asthma care program.
  • Data collected included spirometry, allergy skin testing, and demographic information.
  • Multinomial logistic regression was used to determine risk factors for severe asthma.

Main Results:

  • 87.4% of children had mild to moderate asthma; 66.7% had allergen sensitization.
  • Severe asthma was associated with significantly decreased forced expiratory volume in 1 second/forced vital capacity (FEV1/FVC).
  • Predictors of severe asthma included African-American ethnicity (OR=3.70), Puerto Rican ethnicity (OR=3.55), cockroach allergen sensitization (OR=4.34), and decreased FEV1/FVC (OR=1.06 per 1% decrease).

Conclusions:

  • In Hartford children with asthma, African-American and Puerto Rican ethnicity, cockroach allergen sensitization, and reduced FEV1/FVC are significant predictors of disease severity.
  • FEV1/FVC serves as a valuable indicator for assessing asthma severity in pediatric patients.

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include: